PMID- 23136110 OWN - NLM STAT- MEDLINE DCOM- 20130805 LR - 20220408 IS - 2042-6984 (Electronic) IS - 2042-6976 (Linking) VI - 3 IP - 2 DP - 2013 Feb TI - Noninvasive Staphylococcus aureus biofilm determination in chronic rhinosinusitis by detecting the exopolysaccharide matrix component poly-N-acetylglucosamine. PG - 83-8 LID - 10.1002/alr.21115 [doi] AB - BACKGROUND: The role that bacterial biofilms might play in recalcitrant forms of chronic rhinosinusitis (CRS) is increasingly being recognized. However, the detection of bacteria existing in this form, using standard culture, is limited by their unique metabolically inactive properties. All current biofilm diagnostic modalities require invasive mucosal biopsies, which limit their use to the operating theatre. METHODS: Twenty CRS patients and 5 controls were enrolled in a prospective study to assess the feasibility of noninvasively diagnosing S. aureus biofilms by detecting the biofilm matrix polysaccharide poly-N-acetylglucosamine (PNAG). An immunofluorescence protocol was developed for PNAG detection and compared with both standard microbiological cultures and fluorescence in situ hybridization (FISH). RESULTS: Thirteen of 20 CRS patients had evidence of S. aureus biofilm formation using FISH. Of these, 12 had detectable PNAG. Interestingly none of the S. aureus FISH-negative patients were PNAG-positive despite the presence of coagulase-negative Staphylococci biofilms, some of which may exhibit PNAG in their pathogenic forms. The development of a noninvasive S. aureus biofilm diagnostic test provides a reliable means to identify a high-risk group of CRS patients who harbor S. aureus biofilms. The ability to be used outside of the perioperative period to assess surgical efficacy, guide management, and evaluate new treatment modalities provides a significant advance in this field of research and clinical practice. CONCLUSION: This study has confirmed the feasibility of noninvasive detection of S. aureus biofilms with a simple test that produces results comparable to the more invasive methods that are currently relied upon. CI - (c) 2013 ARS-AAOA, LLC. FAU - Foreman, Andrew AU - Foreman A AD - Department of Otorhinolaryngology-Head and Neck Surgery, Discipline of Surgery, University of Adelaide and Flinders University, Adelaide, Australia. FAU - Jervis-Bardy, Josh AU - Jervis-Bardy J FAU - Boase, Samuel J AU - Boase SJ FAU - Tan, Lorwai AU - Tan L FAU - Wormald, Peter-John AU - Wormald PJ LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20121107 PL - United States TA - Int Forum Allergy Rhinol JT - International forum of allergy & rhinology JID - 101550261 RN - EC 3.5.- (Amidohydrolases) RN - EC 3.5.1.- (poly-N-acetylglucosamine deacetylase) SB - IM MH - Adult MH - Aged MH - Aged, 80 and over MH - Amidohydrolases/*isolation & purification MH - Biofilms/*growth & development MH - Case-Control Studies MH - Chronic Disease MH - Feasibility Studies MH - Female MH - Humans MH - In Situ Hybridization, Fluorescence/methods MH - Male MH - Middle Aged MH - Prospective Studies MH - Rhinitis/*microbiology MH - Sinusitis/*microbiology MH - Staphylococcal Infections/*microbiology MH - Staphylococcus aureus/isolation & purification/*physiology EDAT- 2012/11/09 06:00 MHDA- 2013/08/06 06:00 CRDT- 2012/11/09 06:00 PHST- 2012/05/20 00:00 [received] PHST- 2012/08/29 00:00 [revised] PHST- 2012/09/25 00:00 [accepted] PHST- 2012/11/09 06:00 [entrez] PHST- 2012/11/09 06:00 [pubmed] PHST- 2013/08/06 06:00 [medline] AID - 10.1002/alr.21115 [doi] PST - ppublish SO - Int Forum Allergy Rhinol. 2013 Feb;3(2):83-8. doi: 10.1002/alr.21115. Epub 2012 Nov 7.